Dupixent (dupilumab) has been a breakthrough treatment for people with severe eczema, asthma, and other inflammatory ...

Patients treated with mogamulizumab showed a trend toward improved OS compared to those not receiving mogamulizumab across risk-stratified groups according to the new Cutaneous Lymphoma International ...

RICHMOND, Va. (WRIC) — Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center is the first U.S. site to enroll patients in a global trial of first-in-class therapy for skin-related ...

In a large US cohort study, patients with primary cutaneous B-cell lymphoma (pCBCL) had significantly higher risks of developing hematologic and prostate cancers. Researchers analyzed data from 3757 ...

Overall cancer mortality rates decreased for men, women and children in the U.S. between 2018 and 2022, according to the National Cancer Institute’s “Annual Report to the Nation on the Status of ...